NCT00774969View on ClinicalTrials.gov

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Perianal Crohns'

Interventions

DRUG

Metronidazole

Metronidazole 10% ointment three times a day 7 days

Trial Locations (1)

HA1 3UJ

Sainsbury Wing, St Marks & Northwick Park Hospitals, Watford Road, Harrow

All Listed Sponsors

lead

S.L.A. Pharma AG

INDUSTRY

NCT00774969 - Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease | Biotech Hunter | Biotech Hunter